Dr.Suat Seren EAH

Izmir 35120

0 studies enrolling now · 4 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Idiopathic Pulmonary Fibrosis, Mesothelioma

Studies at this site

• Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis — Completed
• Nintedanib (BIBF 1120) in Mesothelioma — Stopped early
• LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy — Completed
• Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF) — Completed